Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Biodesix Inc.

    NASDAQ: BDSX · Real-Time Price · USD
    0.29
    -0.01 (-4.26%)
    At close: Jun 09, 2025, 3:59 PM

    Biodesix Statistics

    Share Statistics

    Biodesix has 146.56M shares outstanding. The number of shares has increased by 27.28% in one year.

    Shares Outstanding

    n/a
    		 146.56M

    Shares Change (YoY)

    n/a
    		 27.28%

    Shares Change (QoQ)

    n/a
    		 0.35%

    Owned by Institutions (%)

    n/a
    		 40.09%

    Shares Floating

    n/a
    		 69.4M

    Failed to Deliver (FTD) Shares

    n/a
    		 19,707

    FTD / Avg. Volume

    n/a
    		 0.24%

    Short Selling Information

    The latest short interest is 2.48M, so 1.69% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 2.48M

    Short % of Shares Out

    n/a
    		 1.69%

    Short % of Float

    n/a
    		 3.33%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -4.62 and the forward PE ratio is -1.88. Biodesix's PEG ratio is 0.1.

    PE Ratio

    n/a
    		 -4.62

    Forward PE

    n/a
    		 -1.88

    PS Ratio

    n/a
    		 2.78

    Forward PS

    n/a
    		 0.3

    PB Ratio

    n/a
    		 9.5

    P/FCF Ratio

    n/a
    		 -3.82

    PEG Ratio

    n/a
    		 0.1
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Biodesix.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 2.76, with a Debt / Equity ratio of 2.97.

    Current Ratio

    n/a
    		 2.76

    Quick Ratio

    n/a
    		 2.76

    Debt / Equity

    n/a
    		 2.97

    Debt / EBITDA

    n/a
    		 -2.12

    Debt / FCF

    n/a
    		 -1.19

    Interest Coverage

    n/a
    		 -4.18

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $261,256.41

    Profits Per Employee

    n/a
    		 $-157,256.41

    Employee Count

    n/a
    		 273

    Asset Turnover

    n/a
    		 0.73

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -77.44% in the last 52 weeks. The beta is 0.98, so Biodesix's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.98

    52-Week Price Change

    n/a
    		 -77.44%

    50-Day Moving Average

    n/a
    		 0.46

    200-Day Moving Average

    n/a
    		 1.12

    Relative Strength Index (RSI)

    n/a
    		 40.41

    Average Volume (20 Days)

    n/a
    		 8,346,601

    Income Statement

    In the last 12 months, Biodesix had revenue of 71.32M and earned -42.93M in profits. Earnings per share was -0.33.

    Revenue

    n/a
    		 71.32M

    Gross Profit

    n/a
    		 55.75M

    Operating Income

    n/a
    		 -34.5M

    Net Income

    n/a
    		 -42.93M

    EBITDA

    n/a
    		 -29.22M

    EBIT

    n/a
    		 -34.67M

    Earnings Per Share (EPS)

    n/a
    		 -0.33
    Full Income Statement

    Balance Sheet

    The company has 26.25M in cash and 61.98M in debt, giving a net cash position of -35.73M.

    Cash & Cash Equivalents

    n/a
    		 26.25M

    Total Debt

    n/a
    		 61.98M

    Net Cash

    n/a
    		 -35.73M

    Retained Earnings

    n/a
    		 -462.5M

    Total Assets

    n/a
    		 86.24M

    Working Capital

    n/a
    		 16.31M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -48.65M and capital expenditures -3.23M, giving a free cash flow of -51.88M.

    Operating Cash Flow

    n/a
    		 -48.65M

    Capital Expenditures

    n/a
    		 -3.23M

    Free Cash Flow

    n/a
    		 -51.88M

    FCF Per Share

    n/a
    		 -0.4
    Full Cash Flow Statement

    Margins

    Gross margin is 78.17%, with operating and profit margins of -48.37% and -60.19%.

    Gross Margin

    n/a
    		 78.17%

    Operating Margin

    n/a
    		 -48.37%

    Pretax Margin

    n/a
    		 -60.19%

    Profit Margin

    n/a
    		 -60.19%

    EBITDA Margin

    n/a
    		 -40.96%

    EBIT Margin

    n/a
    		 -48.37%

    FCF Margin

    n/a
    		 -72.74%

    Dividends & Yields

    BDSX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for BDSX is $1.75, which is 483.3% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $1.75

    Price Target Difference

    n/a
    		 483.3%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 5
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -7.46

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist